CDC EHE NOFO Allowance for Viral Hepatitis & STD Activities
Topics
Cross-posted from Viral Hepatitis Blog, U.S. Dept of Health & Human Services
A new CDC Notice of Funding Opportunity Announcement (NOFO) that supports implementation of the Ending the HIV Epidemic (EHE) initiative allows the recipients to use up to 10% of the core funding to integrate specific viral hepatitis, STD, and TB activities. This provides the eligible jurisdictions additional opportunities to strengthen integrated services in response to this syndemic.
Eligible applicants for this funding are the 32 health departments that are administering the CDC funds for the 57 jurisdictions prioritized in Phase I (PDF, 146 KB) of the EHE initiative and which recently submitted draft EHE plans for those jurisdictions. Funding will be determined by a formula and will vary by jurisdiction. However, the award floor for the core component is $1.8 million per award.
The NOFO, "Integrated HIV Programs for Health Departments to Support Ending the HIV Epidemic in the United States” (CDC-RFA-PS20-2010), states that the applicants are eligible to use up to 10% of the approved total funding amount to:
- Enhance and expand integrated screening activities (e.g., screening for STDs, viral hepatitis, and/or TB), conducted in conjunction with HIV testing, with accompanying referral for prevention and care services; and/or
- Diagnose and treat STDs for uninsured or underinsured people receiving care in not-for-profit or governmental clinics, when conducted in conjunction with HIV testing and provided that these facilities document their ability to provide safety-net STD clinical preventive services as per CDC guidance. At a minimum, clinics receiving assistance should have the capacity to rapidly diagnose and treat bacterial STDs.
Applicants can propose activities in either or both categories; the total for both categories combined cannot exceed 10% of the core funding awarded.
In addition, a separate, optional component will provide supplemental funding for some jurisdictions to scale up HIV prevention services in STD specialty clinics.
Applications are due on March 25, 2020, and the estimated award date is June 1, 2020.